Progressive, neurodegenerative disease characterized by memory loss.
1Multi-Target approach is particularly promising way to drug discovery against Alzheimer's disease.
2Conclusions: COX activity in Alzheimer's disease varies with stage of the disease.
3Over 70 per cent of doctors surveyed believe Alzheimer's disease is underdiagnosed.
4Right balancing of the pathways is critical for protection against Alzheimer's disease.
5I am worried in case I am developing dementia or Alzheimer's disease?
6Objectives: Dementia in Alzheimer's disease correlates closely with loss of neocortical synapses.
7Genetic factors in patients with Alzheimer's disease are also associated with mercury.
8Their findings could also shed light on the effects of Alzheimer's disease.
9The relationship between cerebrovascular impairment and Alzheimer's disease is a controversial debate.
10Here we review the known genetics of early- and late-onset Alzheimer's disease.
11Clusterin is suggested to be involved in the pathogenesis of Alzheimer's disease.
12Ruffolo's most ambitious efforts have been in developing treatments for Alzheimer's disease.
13Plasma sphingolipids have been shown to predict cognitive decline and Alzheimer's disease.
14Galantamine is an FDA-approved acetylcholinesterase inhibitor used to treat mild-moderate Alzheimer's disease.
15In conclusion, anosognosia is a significant predictor of apathy in Alzheimer's disease.
16Genes identified have been implicated in biological processes relevant to Alzheimer's disease.
Translations for Alzheimer's disease